CHOLESTEROL MANAGEMENT IN CORONARY ARTERY DISEASE: ATORVASTATIN VERSUS ROSUVASTATIN-WHICH TO CHOOSE?
Not Applicable
- Conditions
- Health Condition 1: I259- Chronic ischemic heart disease, unspecified
- Registration Number
- CTRI/2023/04/051592
- Lead Sponsor
- Prof Rajan Joseph Manjuran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
CORONARY ARTERY DISEASE PATIENTS ON STATIN THERAPY EITHER WITH ATORVASTATIN OR ROSUVASTATIN, FOR AT LEAST 3 MONTHS
Exclusion Criteria
PATIENTS WHO ARE NOT WILLING TO GIVE CONSENT
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method